{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T15:30:38Z","timestamp":1791127838133,"version":"4.1.0"},"reference-count":87,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,5,5]],"date-time":"2014-05-05T00:00:00Z","timestamp":1399248000000},"content-version":"vor","delay-in-days":1189,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neoplasia"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1593\/neo.10806","type":"journal-article","created":{"date-parts":[[2015,4,23]],"date-time":"2015-04-23T13:00:31Z","timestamp":1429794031000},"page":"167-IN12","source":"Crossref","is-referenced-by-count":42,"title":["Macitentan (ACT-064992), a Tissue-Targeting Endothelin Receptor Antagonist, Enhances Therapeutic Efficacy of Paclitaxel by Modulating Survival Pathways in Orthotopic Models of Metastatic Human Ovarian Cancer"],"prefix":"10.1016","volume":"13","author":[{"given":"Sun-Jin","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jang Seong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung Wook","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Brantley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seok Joong","family":"Yun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junqin","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marva","family":"Maya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fahao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuyu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Lehembre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Urs","family":"Regenass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isaiah J.","family":"Fidler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1593\/neo.10806_bib1","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3322\/caac.20006","article-title":"Cancer statistics","volume":"59","author":"Jemal","year":"2009","journal-title":"CA Cancer J Clin"},{"key":"10.1593\/neo.10806_bib2","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1056\/NEJM199311183292108","article-title":"Cancer of the ovary","volume":"329","author":"Cannistra","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1593\/neo.10806_bib3","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1093\/jnci\/djg036","article-title":"A randomized clinical trial of cisplatin\/paclitaxel versus carboplatin\/paclitaxel as first-line treatment of ovarian cancer","volume":"9","author":"du Bois","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"10.1593\/neo.10806_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM199601043340101","article-title":"Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer","volume":"334","author":"McGuire","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1593\/neo.10806_bib5","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1200\/JCO.1996.14.6.1895","article-title":"Carboplatin and paclitaxel in ovarian carcinoma: a phase I study of the Gynecologic Oncology Group","volume":"14","author":"Bookman","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1593\/neo.10806_bib6","series-title":"American Society of Clinical Oncology 2001 Education Book","first-page":"468","article-title":"Treatment of relapsed epithelial ovarian cancer","author":"Gore","year":"2001"},{"key":"10.1593\/neo.10806_bib7","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1093\/jnci\/87.21.1588","article-title":"Modulation of the organ microenvironment for the treatment of cancer metastasis","volume":"87","author":"Fidler","year":"1995","journal-title":"J Natl Cancer Inst"},{"key":"10.1593\/neo.10806_bib8","first-page":"1200","article-title":"Blockade of epidermal growth factor receptor signaling in tumor cells and tumor-associated endothelial cells for therapy of androgen-independent human prostate cancer growing in the bone of nude mice","volume":"9","author":"Kim","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.1593\/neo.10806_bib9","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1056\/NEJM199508103330607","article-title":"Endothelins","volume":"333","author":"Levin","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1593\/neo.10806_bib10","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1097\/00005344-200000002-00002","article-title":"The endothelin family: an overview","volume":"35","author":"Masaki","year":"2000","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1593\/neo.10806_bib11","doi-asserted-by":"crossref","first-page":"10851","DOI":"10.1016\/S0021-9258(18)81698-2","article-title":"Structural organization and chromosomal assignment of the gene encoding endothelin","volume":"264","author":"Bloch","year":"1989","journal-title":"J Biol Chem"},{"key":"10.1593\/neo.10806_bib12","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/0196-9781(93)90057-N","article-title":"Growth regulatory properties of endothelins","volume":"14","author":"Battistini","year":"1993","journal-title":"Peptides"},{"key":"10.1593\/neo.10806_bib13","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1046\/j.1440-1681.1999.03014.x","article-title":"Endothelins in health and disease: an overview","volume":"26","author":"Goldie","year":"1999","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1593\/neo.10806_bib14","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1038\/nrd962","article-title":"New therapeutics that antagonize endothelin: promises and frustrations","volume":"1","author":"Remuzzi","year":"2002","journal-title":"Nat Rev Drug Discov"},{"key":"10.1593\/neo.10806_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1054-3589(08)60665-1","article-title":"Endothelin receptor antagonism","volume":"33","author":"Opgenorth","year":"1995","journal-title":"Adv Pharmacol"},{"key":"10.1593\/neo.10806_bib16","first-page":"1434","article-title":"Endothelins and endothelin receptor antagonists: therapeutic considerations for a novel class cardiovascular drugs","volume":"102","author":"Lusher","year":"2000","journal-title":"Circulation"},{"key":"10.1593\/neo.10806_bib17","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1097\/00005344-200000002-00015","article-title":"Endothelin receptor antagonists: current status and perspectives","volume":"35","author":"Clozel","year":"2000","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1593\/neo.10806_bib18","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.1091\/mbc.E03-12-0902","article-title":"Endothelin-1 promotes myofibroblasts induction through the ETA receptor via a rac\/phosphoinositide 3-kinase\/Akt-dependent pathway and is essential for the enhanced contractile phenotype of fibrotic fibroblasts","volume":"15","author":"Shi-Wen","year":"2004","journal-title":"Mol Biol Cell"},{"key":"10.1593\/neo.10806_bib19","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1161\/01.CIR.100.1.5","article-title":"Endothelin-1 potentiates human smooth muscle cell growth to PDGF: effects of ETA and ETB receptor blockade","volume":"100","author":"Yang","year":"1999","journal-title":"Circulation"},{"key":"10.1593\/neo.10806_bib20","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1165\/ajrcmb.23.1.4030","article-title":"Pulmonary fibrosis and chronic lung inflammation in ET-1 transgenic mice","volume":"23","author":"Hocher","year":"2000","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1593\/neo.10806_bib21","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nrc990","article-title":"The endothelin axis: emerging role in cancer","volume":"3","author":"Nelson","year":"2003","journal-title":"Nature Rev Cancer"},{"key":"10.1593\/neo.10806_bib22","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1158\/0008-5472.CAN-08-1879","article-title":"Endothelin-1 stimulates lymphatic endothelial cells and lymphatic vessels to grow and invade","volume":"69","author":"Spinella","year":"2009","journal-title":"Cancer Res"},{"key":"10.1593\/neo.10806_bib23","doi-asserted-by":"crossref","first-page":"3209","DOI":"10.1158\/0008-5472.CAN-03-1291","article-title":"Endothelin-1 is a critical mediator of mitogenic tone in tumor arterioles: implications for cancer treatment","volume":"64","author":"Sonveaux","year":"2004","journal-title":"Cancer Res"},{"key":"10.1593\/neo.10806_bib24","doi-asserted-by":"crossref","first-page":"11649","DOI":"10.1158\/0008-5472.CAN-05-2123","article-title":"Endothelin-1 promotes epithelial-to-mesenchymal transition in human ovarian cancer cells","volume":"65","author":"Rosan\u00f2","year":"2005","journal-title":"Cancer Res"},{"key":"10.1593\/neo.10806_bib25","first-page":"8340","article-title":"Endothelin-1 induces tumor proteinase activation and invasiveness of ovarian carcinoma cells","volume":"61","author":"Rosan\u00f2","year":"2001","journal-title":"Cancer Res"},{"key":"10.1593\/neo.10806_bib26","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1165\/rcmb.2008-0447OC","article-title":"Endothelin-1 and transforming growth factor-\u03b21 independently induce fibroblast resistance to apoptosis via AKT activation","volume":"41","author":"Kulasekaran","year":"2009","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1593\/neo.10806_bib27","first-page":"44","article-title":"Endothelium-derived factors as paracrine mediators of prostate cancer progression","volume":"44","author":"Pristivishalil","year":"2000","journal-title":"Prostate"},{"key":"10.1593\/neo.10806_bib28","first-page":"663","article-title":"Endothelin-1 production and decreased endothelin B receptor expression in advanced prostate cancer","volume":"56","author":"Nelson","year":"1996","journal-title":"Cancer Res"},{"key":"10.1593\/neo.10806_bib29","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1165\/ajrcmb.22.4.3795","article-title":"Studies on the expression of endothelin, its receptor subtypes, and converting enzymes in lung cancer and in human bronchial epithelium","volume":"22","author":"Ahmed","year":"2000","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"suppl 3","key":"10.1593\/neo.10806_bib30","doi-asserted-by":"crossref","first-page":"S341","DOI":"10.1097\/00005344-199506263-00102","article-title":"Localization and characterization of endothelin-1 receptor binding in the blood vessels of human pulmonary tumors","volume":"26","author":"Zhao","year":"1995","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1593\/neo.10806_bib31","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1054\/bjoc.2001.2193","article-title":"Increased endothelin-1 in colorectal cancer and reduction of tumour growth by ET(A) receptor antagonism","volume":"85","author":"Asham","year":"2001","journal-title":"Br J Cancer"},{"key":"10.1593\/neo.10806_bib32","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1002\/(SICI)1097-0215(20000415)86:2<182::AID-IJC6>3.0.CO;2-G","article-title":"Endothelin receptor blockade potentiates FasL-induced apoptosis in rat colon carcinoma cells","volume":"86","author":"Eberl","year":"2000","journal-title":"Int J Cancer"},{"key":"10.1593\/neo.10806_bib33","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.canlet.2006.02.007","article-title":"Endothelin-1 promotes cell survival in renal cell carcinoma through the ET(A) receptor","volume":"246","author":"Pflug","year":"2007","journal-title":"Cancer Lett"},{"key":"10.1593\/neo.10806_bib34","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1096\/fj.00-0024com","article-title":"Expression of endothelin 1 and endothelin A receptor in HPV-associated cervical carcinoma: new potential targets for anticancer therapy","volume":"14","author":"Venuti","year":"2000","journal-title":"FASEB J"},{"key":"10.1593\/neo.10806_bib35","first-page":"6381","article-title":"Growth inhibition of cervix carcinoma cells in vivo by endothelin A receptor blockade","volume":"62","author":"Bagnato","year":"2002","journal-title":"Cancer Res"},{"key":"10.1593\/neo.10806_bib36","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1172\/JCI118249","article-title":"Expression and localization of endothelin-1 and endothelin receptors in human meningiomas. Evidence for a role in tumoral growth","volume":"96","author":"Pagotto","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1593\/neo.10806_bib37","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1097\/00006123-199810000-00097","article-title":"Expression of endothelin( A) receptors in human gliomas and meningiomas, with high affinity for the selective antagonist PD156707","volume":"43","author":"Harland","year":"1998","journal-title":"Neurosurgery"},{"key":"10.1593\/neo.10806_bib38","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1038\/labinvest.3780178","article-title":"The endothelin system in human glioblastoma","volume":"80","author":"Egidy","year":"2000","journal-title":"Lab Invest"},{"key":"10.1593\/neo.10806_bib39","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1158\/1535-7163.MCT-07-0151","article-title":"ZD4054, a specific antagonist of the endothelin A receptor, inhibits tumor growth and enhances paclitaxel activity in human ovarian carcinoma in vitro and in vivo","volume":"6","author":"Rosan\u00f2","year":"2007","journal-title":"Mol Cancer Ther"},{"key":"10.1593\/neo.10806_bib40","doi-asserted-by":"crossref","first-page":"6351","DOI":"10.1158\/0008-5472.CAN-07-0883","article-title":"Combined targeting of endothelin A receptor and epidermal growth factor receptor in ovarian cancer shows enhanced antitumor activity","volume":"67","author":"Rosan\u00f2","year":"2007","journal-title":"Cancer Res"},{"key":"10.1593\/neo.10806_bib41","first-page":"5310","article-title":"Transactivation of the epidermal growth factor receptor in endothelin-1-induced mitogenic signaling in human ovarian carcinoma cells","volume":"60","author":"Vacca","year":"2000","journal-title":"Cancer Res"},{"key":"10.1593\/neo.10806_bib42","doi-asserted-by":"crossref","first-page":"9265","DOI":"10.1158\/0008-5472.CAN-08-2093","article-title":"Small interfering RNA molecules targeting endothelin-converting enzyme-1 inhibit endothelin-1 synthesis and the invasive phenotype of ovarian carcinoma cells","volume":"68","author":"Rayhman","year":"2008","journal-title":"Cancer Res"},{"key":"10.1593\/neo.10806_bib43","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1016\/S0002-9440(10)64791-8","article-title":"Role of endothelin-1 in neovascularization of ovarian carcinoma","volume":"157","author":"Salani","year":"2000","journal-title":"Am J Pathol"},{"key":"10.1593\/neo.10806_bib44","first-page":"720","article-title":"Expression of endothelin 1 and endothelin A receptor in ovarian carcinoma: evidence for an autocrine role in tumor growth","volume":"59","author":"Bagnato","year":"1999","journal-title":"Cancer Res"},{"key":"10.1593\/neo.10806_bib45","first-page":"1059","article-title":"Autocrine actions of endothelin-1 as a growth factor in human ovarian carcinoma cells","volume":"1","author":"Bagnato","year":"1995","journal-title":"Clin Cancer Res"},{"key":"10.1593\/neo.10806_bib46","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S0959-8049(97)00012-9","article-title":"Endothelin expression and responsiveness in human ovarian carcinoma cell lines","volume":"33","author":"Moraitis","year":"1997","journal-title":"Eur J Cancer"},{"key":"10.1593\/neo.10806_bib47","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1016\/S0959-8049(99)00131-8","article-title":"Paracrine regulation of ovarian cancer by endothelin","volume":"35","author":"Moraitis","year":"1999","journal-title":"Eur J Cancer"},{"key":"10.1593\/neo.10806_bib48","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.1073\/pnas.0807158106","article-title":"\u03b2-Arrestin links endothelin A receptor to \u03b2-catenin signaling to induce ovarian cancer cell invasion and metastasis","volume":"106","author":"Rosan\u00f2","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1593\/neo.10806_bib49","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1080\/07357900701522588","article-title":"Endothelin receptor antagonists in cancer therapy","volume":"25","author":"Lalich","year":"2007","journal-title":"Cancer Invest"},{"key":"10.1593\/neo.10806_bib50","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1016\/j.biocel.2008.01.022","article-title":"The endothelin axis in cancer","volume":"40","author":"Bagnato","year":"2008","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1593\/neo.10806_bib51","first-page":"3257","article-title":"Production of endothelin in human cancer cell lines","volume":"50","author":"Kusuhara","year":"1990","journal-title":"Cancer Res"},{"key":"10.1593\/neo.10806_bib52","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1387\/ijdb.041951rl","article-title":"Endothelin receptor B is required for the expansion of melanocyte precursors and malignant melanoma","volume":"49","author":"Lahav","year":"2005","journal-title":"Int J Dev Biol"},{"issue":"2 pt 2","key":"10.1593\/neo.10806_bib53","first-page":"H686","article-title":"Proliferation and migration of endothelial cells is promoted by endothelins via activation of ETB receptors","volume":"269","author":"Morbidelli","year":"1995","journal-title":"Am J Physiol"},{"issue":"suppl 3","key":"10.1593\/neo.10806_bib54","doi-asserted-by":"crossref","first-page":"S284","DOI":"10.1097\/00005344-199526003-00085","article-title":"ETB receptors promote proliferation and migration of endothelial cells","volume":"26","author":"Ziche","year":"1995","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1593\/neo.10806_bib55","doi-asserted-by":"crossref","first-page":"309","DOI":"10.2174\/157016105774329462","article-title":"Endothelin-1 and angiogenesis in cancer","volume":"3","author":"Knowles","year":"2005","journal-title":"Curr Vasc Pharmacol"},{"key":"10.1593\/neo.10806_bib56","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1016\/S0002-9440(10)64807-9","article-title":"Endothelin-1 induces an angiogenic phenotype in cultured endothelial cells and stimulates neovascularization in vivo","volume":"157","author":"Salani","year":"2000","journal-title":"Am J Pathol"},{"key":"10.1593\/neo.10806_bib57","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1016\/S0002-9440(10)64825-0","article-title":"Modulation of human colon tumor-stromal interactions by the endothelin system","volume":"157","author":"Egidy","year":"2000","journal-title":"Am J Pathol"},{"key":"10.1593\/neo.10806_bib58","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1677\/erc.1.01077","article-title":"Emerging role of the endothelin axis in ovarian tumor progression","volume":"12","author":"Bagnato","year":"2005","journal-title":"Endocr Relat Cancer"},{"key":"10.1593\/neo.10806_bib59","doi-asserted-by":"crossref","first-page":"27850","DOI":"10.1074\/jbc.M202421200","article-title":"Endothelin-1 induces vascular endothelial growth factor by increasing hypoxia-inducible factor-1\u03b1 in ovarian carcinoma cells","volume":"277","author":"Spinella","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1593\/neo.10806_bib60","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0031-6997(25)06809-7","article-title":"Endothelins: molecular biology, biochemistry, pharmacology, physiology, and pathophysiology","volume":"46","author":"Rubanyi","year":"1994","journal-title":"Pharmacol Rev"},{"key":"10.1593\/neo.10806_bib61","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1124\/jpet.108.142976","article-title":"Pharmacology of macitentan, an orally active tissue targeting dual endothelin receptor antagonist","volume":"327","author":"Iglarz","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1593\/neo.10806_bib62","doi-asserted-by":"crossref","first-page":"4923","DOI":"10.1158\/1078-0432.CCR-04-2060","article-title":"Antivascular therapy for orthotopic human ovarian carcinoma through blockade of the vascular endothelial growth factor and epidermal growth factor receptors","volume":"11","author":"Thaker","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1593\/neo.10806_bib63","first-page":"4970","article-title":"Characterization of a human ovarian adenocarcinoma line, IGROV1, in tissue culture and in nude mice","volume":"45","author":"B\u00e9nard","year":"1985","journal-title":"Cancer Res"},{"key":"10.1593\/neo.10806_bib64","first-page":"2971","article-title":"Tissue-specific microvascular endothelial cell lines from H-2K(b)-tsA58 mice for studies of angiogenesis and metastasis","volume":"63","author":"Langley","year":"2003","journal-title":"Cancer Res"},{"key":"10.1593\/neo.10806_bib65","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/nm1699","article-title":"Endothelin B receptor mediates the endothelial barrier to T cell homing to tumors and disables immune therapy","volume":"14","author":"Buckanovich","year":"2008","journal-title":"Nat Med"},{"key":"10.1593\/neo.10806_bib66","doi-asserted-by":"crossref","first-page":"8065","DOI":"10.1038\/sj.onc.1207959","article-title":"Whole genome expression profiling of advance stage papillary serous ovarian cancer reveals activated pathways","volume":"23","author":"Donninger","year":"2004","journal-title":"Oncogene"},{"key":"10.1593\/neo.10806_bib67","doi-asserted-by":"crossref","first-page":"245.e1","DOI":"10.1016\/j.ajog.2006.10.874","article-title":"Gene expression profile of ovarian serous papillary carcinomas: identification of metastasis-associated genes","volume":"196","author":"Bignotti","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"10.1593\/neo.10806_bib68","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1593\/neo.06388","article-title":"Endothelin receptor A blockade enhances taxane effects in prostate cancer","volume":"8","author":"Akhavan","year":"2006","journal-title":"Neoplasia"},{"key":"10.1593\/neo.10806_bib69","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1517\/14728220903074570","article-title":"Therapeutic potential of endothelin receptor modulators: lessons from human clinical trials","volume":"13","author":"Aubert","year":"2009","journal-title":"Expert Opin Ther Targets"},{"key":"10.1593\/neo.10806_bib70","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/s11912-006-0045-1","article-title":"Endothelin receptor antagonists: rationale, clinical development, and role in prostate cancer therapeutics","volume":"8","author":"Thakkar","year":"2006","journal-title":"Curr Oncol Rep"},{"key":"10.1593\/neo.10806_bib71","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/j.eururo.2008.11.002","article-title":"Safety and efficacy of the specific endothelin-A receptor antagonist ZD4054 in patients with hormone-resistant prostate cancer and bone metastases who were pain free or mildly symptomatic: a double-blind, placebo-controlled, randomized, phase 2 trial","volume":"55","author":"James","year":"2009","journal-title":"Eur Urol"},{"key":"10.1593\/neo.10806_bib72","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s10637-006-9014-7","article-title":"A phase II study of Bosentan, a dual endothelin receptor antagonist, as monotherapy in patients with stage IV metastatic melanoma","volume":"25","author":"Kefford","year":"2007","journal-title":"Invest New Drugs"},{"key":"10.1593\/neo.10806_bib73","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/0092-8674(94)90018-3","article-title":"Interaction of endothelin-3 with endothelin-B receptor is essential for development of epidermal melanocytes and enteric neurons: missense mutation of endothelin-3 gene in lethal spotting mice","volume":"79","author":"Baynash","year":"1994","journal-title":"Cell"},{"key":"10.1593\/neo.10806_bib74","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s004280000362","article-title":"Expression of the endothelin-B receptor in pigment cell lesions of the skin: evidence for its role as tumor progression marker in malignant melanoma","volume":"438","author":"Demunter","year":"2001","journal-title":"Virchows Arch"},{"key":"10.1593\/neo.10806_bib75","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/1476-4598-9-69","article-title":"A randomized, double-blind, placebo-controlled study of high-dose bosentan in patients with stage IV metastatic melanoma receiving first-line dacarbazine chemotherapy","volume":"9","author":"Kefford","year":"2010","journal-title":"Mol Cancer"},{"key":"10.1593\/neo.10806_bib76","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1159\/000102534","article-title":"Endothelin-1-induced pulmonary vasoreactivity is regulated by ETA and ETB receptor interactions","volume":"44","author":"Sauvageau","year":"2007","journal-title":"J Vasc Res"},{"key":"10.1593\/neo.10806_bib77","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/S0741-5214(98)70096-5","article-title":"Endothelin-B receptors mediate intimal hyperplasia in an organ culture of human saphenous vein","volume":"28","author":"Porter","year":"1998","journal-title":"J Vasc Surg"},{"key":"10.1593\/neo.10806_bib78","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1161\/01.HYP.36.2.282","article-title":"Effect of bosentan on NF-\u03baB, inflammation, and tissue factor in angiotensin II-induced end-organ damage","volume":"36","author":"Muller","year":"2000","journal-title":"Hypertension"},{"key":"10.1593\/neo.10806_bib79","first-page":"1132","article-title":"ZD4054, a potent endothelin receptor A antagonist, inhibits ovarian carcinoma cell proliferation","volume":"231","author":"Rosan\u00f2","year":"2006","journal-title":"Exp Biol Med"},{"key":"10.1593\/neo.10806_bib80","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s10549-009-0644-2","article-title":"ETAR antagonist ZD4054 exhibits additive effects with aromatase inhibitors and fulvestrant in breast cancer therapy and improves in vivo efficacy of anastrozole","volume":"123","author":"Smollich","year":"2010","journal-title":"Breast Cancer Res Treat"},{"key":"10.1593\/neo.10806_bib81","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1158\/1535-7163.MCT-05-0523","article-title":"Integrin-linked kinase functions as a downstream mediator of endothelin-1 to promote invasive behavior in ovarian carcinoma","volume":"5","author":"Rosan\u00f2","year":"2006","journal-title":"Mol Cancer Ther"},{"key":"10.1593\/neo.10806_bib82","first-page":"1306","article-title":"Activation of mitogenic signaling by endothelin 1 in ovarian carcinoma cells","volume":"57","author":"Bagnato","year":"1997","journal-title":"Cancer Res"},{"issue":"suppl 48","key":"10.1593\/neo.10806_bib83","doi-asserted-by":"crossref","first-page":"302S","DOI":"10.1042\/CS103S302S","article-title":"Endothelin-1 acts as a survival factor in ovarian carcinoma cells","author":"Del Bufalo","year":"2002","journal-title":"Clin Sci (Lond)"},{"key":"10.1593\/neo.10806_bib84","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1126\/science.1109237","article-title":"Transduction of receptor signals by \u03b2-arrestin","volume":"308","author":"Lefkowitz","year":"2005","journal-title":"Science"},{"key":"10.1593\/neo.10806_bib85","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1593\/neo.05193","article-title":"Induction of apoptosis in tumorassociated endothelial cells and therapy of orthotopic human pancreatic carcinoma in nude mice","volume":"7","author":"Yokoi","year":"2005","journal-title":"Neoplasia"},{"key":"10.1593\/neo.10806_bib86","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/pros.20283","article-title":"Dual inhibition of the epidermal growth factor receptor and vascular endothelial growth factor phosphorylation for antivascular therapy of human prostate cancer in the prostate of nude mice","volume":"65","author":"Yazici","year":"2005","journal-title":"Prostate"},{"key":"10.1593\/neo.10806_bib87","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1093\/jnci\/djj211","article-title":"Targeting platelet-derived growth factor receptor on endothelial cells of multidrug resistant prostate cancer","volume":"98","author":"Kim","year":"2006","journal-title":"J Natl Cancer Inst"}],"container-title":["Neoplasia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558611800552?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558611800552?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T21:52:41Z","timestamp":1747950761000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1476558611800552"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2]]},"references-count":87,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["S1476558611800552"],"URL":"https:\/\/doi.org\/10.1593\/neo.10806","relation":{},"ISSN":["1476-5586"],"issn-type":[{"value":"1476-5586","type":"print"}],"subject":[],"published":{"date-parts":[[2011,2]]}}}